Pharmacy Staff Resource Requirements for New Health Technology Appraisal (HTA) Approved Drugs BOPA Questionnaire

The Audit and Research committee would like to invite you to complete the following survey looking at the pharmacy staff resource requirements for new HTA drugs.

Click HERE to complete the survey

The number of cancer technology appraisals has increased dramatically over the last couple of years and this has led to an increasing amount of pressure on the NHS to implement and deliver these innovative new medicines to patients.

The issue of protocols has been raised multiple times at our annual conference and educational events by the membership. This questionnaire is looking to quantify the pharmacy resource required across England, Wales, Scotland and NI to undertake this process. As a result of the survey, BOPA will look at ways to help reduce this duplication.

Please take the time to complete this important survey by the 18th June.

The survey will take approximately 10minutes to complete.

Melanie Dalby, Rich Allen and the A&R committee

 

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article